Related Experiment Video
Updated: May 23, 2026
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Why Single-Cell Sequencing Has Promise in MDS
Xuan Zhang1, H Leighton Grimes1,2,3
1Division of Immunobiology and Center for Systems Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Abstract:
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by ineffective hematopoiesis. The risk of MDS is associated with aging and the accumulation of somatic mutations in hematopoietic stem cells and progenitors (HSPC). While advances in DNA sequencing in the past decade unveiled clonal selection driven by mutations in MDS, it is unclear at which stage the HSPCs are trapped or what prevents mature cells output. Single-cell-sequencing techniques in recent years have revolutionized our understanding of normal hematopoiesis by identifying the transitional cell states between classical hematopoietic hierarchy stages, and most importantly the biological activities behind cell differentiation and lineage commitment. Emerging studies have adapted these powerful tools to investigate normal hematopoiesis as well as the clonal heterogeneity in myeloid malignancies and provide a progressive description of disease pathogenesis. This review summarizes the potential of growing single-cell-sequencing techniques, the evolving efforts to elucidate hematopoiesis in physiological conditions and MDS at single-cell resolution, and discuss how they may fill the gaps in our current understanding of MDS biology.
Insights
Single-cell sequencing reveals how aging and mutations disrupt blood stem cell development in myelodysplastic syndromes (MDS). This technology helps understand why mature blood cells fail to develop properly in MDS patients.
Area of Science:
- Hematology
- Genomics
- Cell Biology
Background:
- Myelodysplastic syndromes (MDS) are linked to aging and somatic mutations in hematopoietic stem and progenitor cells (HSPCs).
- Current understanding of MDS pathogenesis is limited regarding HSPC dysfunction and mature cell output failure.
- Advances in DNA sequencing have identified clonal selection in MDS but not the specific cellular stages affected.
Purpose of the Study:
- To review the application of single-cell sequencing in understanding normal hematopoiesis and MDS.
- To elucidate the role of transitional cell states in normal and malignant hematopoiesis.
- To discuss how single-cell resolution can fill knowledge gaps in MDS biology.
Main Methods:
- Review of emerging studies utilizing single-cell sequencing techniques.
- Analysis of research on normal hematopoiesis at single-cell resolution.
- Examination of studies investigating clonal heterogeneity in myeloid malignancies using single-cell data.
Main Results:
- Single-cell sequencing identifies transitional cell states in normal hematopoiesis, revealing differentiation and lineage commitment mechanisms.
- These techniques are increasingly adapted to study myeloid malignancies, offering insights into disease pathogenesis.
- Emerging studies provide a progressive description of MDS pathogenesis at single-cell resolution.
Conclusions:
- Single-cell sequencing holds significant potential for advancing MDS research.
- Further application of these techniques is crucial for a comprehensive understanding of hematopoiesis in physiological conditions and MDS.
- Elucidating MDS biology at single-cell resolution may reveal novel therapeutic targets and improve patient outcomes.
Related Concept Videos
03:00Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
03:21RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...